Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1412-8. doi: 10.1016/j.pnpbp.2010.07.019. Epub 2010 Jul 24.

Abstract

Schizophrenia (SCZ) is a severe neuropsychiatric disorder with prominent genetic etiologic factors. The dopamine receptor DRD3 gene is a strong candidate in genetic studies of SCZ because of the dopamine hypothesis of SCZ and the selective expression of D(3) in areas of the limbic system implicated in the disease. We examined 15 single-nucleotide polymorphisms (SNPs) in DRD3 in our sample of European origin consisting of 95 small nuclear SCZ families and 167 case-control pairs. We also examined four BDNF SNPs in our samples because of evidence for BDNF regulation of DRD3 expression (Guillin et al., 2001). We found a nominally significant genotypic association with rs7633291 and allelic association with rs1025398 alleles. However, these observations did not survive correction for multiple testing. We did not find a statistically significant association with the other DRD3 and BDNF polymorphisms. Taken together, the results from the present study suggest that BDNF and DRD3 may not be involved in SCZ susceptibility.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain-Derived Neurotrophic Factor / genetics*
  • Case-Control Studies
  • Family
  • Female
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics
  • Genome-Wide Association Study / methods*
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics
  • Receptors, Dopamine D3 / genetics*
  • Research Design
  • Schizophrenia / diagnosis*
  • Schizophrenia / genetics*

Substances

  • Brain-Derived Neurotrophic Factor
  • Genetic Markers
  • Receptors, Dopamine D3